Anticorps Recombinant de lapin anti-CXCL9/MIG

CXCL9/MIG Recombinant Antibody for FC (Intra)

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

FC (Intra)

Conjugaison

APC-Cyanine7 Fluorescent Dye

CloneNo.

241437F5

N° de cat : AY7-FcA98211

Synonymes

CXCL9, MIG, MIG; CXCL9, 241437F5, CMK



Applications testées

Résultats positifs en FC (Intra)IFN gamma, TNF α and Brefeldin A treated human PBMCs,

Dilution recommandée

ApplicationDilution
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 ul per 10^6 cells in a 100 µl suspension or 5 ul per 100 µl of whole blood.
Sample-dependent, check data in validation data gallery

Informations sur le produit

AY7-FcA98211 cible CXCL9/MIG dans les applications de FC (Intra) et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène CXCL9/MIG Protéine recombinante Ag17932
Nom complet chemokine (C-X-C motif) ligand 9
Masse moléculaire calculée 14 kDa
Numéro d’acquisition GenBankBC095396
Symbole du gène CXCL9
Identification du gène (NCBI) 4283
Conjugaison APC-Cyanine7 Fluorescent Dye
Excitation/Emission maxima wavelengths650 nm / 778 nm
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 0.09% sodium azide and 0.5% BSA
Conditions de stockageStore at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

Informations générales

CXCL9 is a small cytokine known as MIG. CXCL9 is a T-cell chemoattractant, which is induced by IFN-γ. It is closely related to two other CXC chemokines called CXCL10 and CXCL11, whose genes are located near the gene for CXCL9 on human chromosome 4. A high level of CXCL9 revealed in peripheral liquids, can be considered as a marker of host immune response, especially of that involving Th1 cells.

Protocole

Product Specific Protocols
FC protocol for APC-Cyanine7 CXCL9/MIG antibody AY7-FcA98211Download protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}